| Table 5. Pregnancy outcomes in DGC and Microfluidics (MC) groups stratified by baseline DNA fragmentation index (DFI)Values are presented as number of cases (percentage). Outcomes are compared between patients with low (DFI < 15%) and high (DFI ≥ 15%) DNA fragmentation in each group. No statistically significant differences were observed in pregnancy, clinical pregnancy, ongoing pregnancy, or live birth rates between subgroups. | |||||
| Outcome | DGC group (n=49) | MC group (n=54) | p-value | ||
|---|---|---|---|---|---|
| DFI < 15% (n=37) (1) |
DFI ≥15% (n=12) (2) |
DFI < 15% (n=40) (3) |
DFI ≥15% (n=14) (4) |
||
| Pregnancy rate | 29 (78.4%) | 8 (66.7%) | 30 (75.0%) | 9 (64.3%) | p1-2=0.454 p3-4=0.441 p2-4=1.000 |
| Clinical pregnancy rate | 25 (67.6%) | 8 (66.7%) | 26 (65.0%) | 9 (64.3%) | p1-2=1.000 p3-4=0.961 p2-4=1.000 |
| Ongoing pregnancy rate | 24 (64.9%) | 7 (58.3%) | 25 (62.5%) | 7 (50.0%) | p1-2=0.683 p3-4=0.412 p2-4=0.712 |
| Live birth rate | 24 (64.9%) | 7 (58.3%) | 25 (62.5%) | 7 (50.0%) | p1-2=0.683 p3-4=0.412 p2-4=0.712 |